Search

everythinglearnresearchcommunity

for

Search:↓

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

MOTILIPERM may help treat male infertility by reducing stress in cells.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

Androgens may influence bladder cancer progression by affecting cellular behavior.

The treatment is safe and shows promise for metastatic breast cancer.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Androgenetic alopecia negatively impacts quality of life, especially for women, due to social reactions.

The Spanish version of the WAA-QoL questionnaire is reliable and valid for assessing quality of life in women with hair loss.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.